Advertisement ePRO in Action for Phase II - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about

ePRO in Action for Phase II

CASE STUDIES
By

Sanofi Pasteur had used electronic patient reported outcome (ePRO) solutions provider PHT Corporation in previous trials. "eDiaries motivate subjects to complete their daily questionnaires. In addition, it is much more efficacious to ask subjects how they feel at a precise moment and get an immediate, accurate answer," said Vicki Tyler, Clinical Trial Manager at Sanofi Pasteur's Massachusetts facility, who oversees the Clostridium difficile study

Quick Contact


Top Products from